Matches in SemOpenAlex for { <https://semopenalex.org/work/W4323643003> ?p ?o ?g. }
- W4323643003 abstract "Adverse limb events after endovascular therapy (EVT) are a major concern. This study aimed to investigate the relationship between serum malondialdehyde-modified low-density lipoprotein (MDA-LDL) level, a potentially potent indicator of atherosclerosis, and clinical outcomes after EVT in patients with lower extremity arterial disease (LEAD).A total of 208 LEAD patients who underwent EVT and MDA-LDL measurements were retrospectively analyzed. Those with chronic limb-threatening ischemia (CLTI) were included in the CLTI subgroup (n=106). Patients were further categorized into the High or Low MDA-LDL groups according to the cut-off value calculated by receiver operating characteristic analysis. Major adverse limb events (MALE), a composite of cardiovascular death, limb-related death, major amputation, and target-limb revascularization, were evaluated.MALE occurred in 73 (35%) patients. The median follow-up interval was 17.4 months. The MDA-LDL cut-off values were 100.5 U/L (area under the curve [AUC] 0.651) in the overall population and 98.0 U/L (AUC 0.724) in the CLTI subgroup. Overall, the High MDA-LDL group showed significantly higher total cholesterol (189.7±37.5 mg/dL vs. 159.3±32.0 mg/dL, p<0.01), low-density lipoprotein cholesterol (114.3± 29.7 mg/dL vs. 87.3±25.3 mg/dL, p<0.01), and triglyceride (166.9±91.1 mg/dL vs. 115.8±52.3 mg/dL, p< 0.01) than the Low MDA-LDL group. Multivariate Cox regression analyses revealed that MDA-LDL and C-reactive protein were independent predictors of MALE. In the CLTI subgroup, MDA-LDL was an independent predictor of MALE. The High MDA-LDL group showed worse MALE-free survival rates than the Low MDA-LDL group in overall (p<0.01) and in the CLTI subgroup (p=0.01).Serum MDA-LDL level was associated with MALE after EVT." @default.
- W4323643003 created "2023-03-10" @default.
- W4323643003 creator A5002054394 @default.
- W4323643003 creator A5023712329 @default.
- W4323643003 creator A5029722966 @default.
- W4323643003 creator A5034236679 @default.
- W4323643003 creator A5040423588 @default.
- W4323643003 creator A5059106599 @default.
- W4323643003 creator A5067280358 @default.
- W4323643003 creator A5068758580 @default.
- W4323643003 creator A5085405229 @default.
- W4323643003 creator A5087008302 @default.
- W4323643003 creator A5088588767 @default.
- W4323643003 creator A5089100272 @default.
- W4323643003 date "2023-01-01" @default.
- W4323643003 modified "2023-10-01" @default.
- W4323643003 title "Malondialdehyde-Modified Low-Density Lipoprotein as a Predictor of Major Adverse Limb Events after Endovascular Therapy in Patients with Lower Extremity Arterial Disease" @default.
- W4323643003 cites W1761241349 @default.
- W4323643003 cites W1977216783 @default.
- W4323643003 cites W1993324234 @default.
- W4323643003 cites W2043517681 @default.
- W4323643003 cites W2067261742 @default.
- W4323643003 cites W2082643036 @default.
- W4323643003 cites W2114447765 @default.
- W4323643003 cites W2116086363 @default.
- W4323643003 cites W2131825316 @default.
- W4323643003 cites W2159506419 @default.
- W4323643003 cites W2164063906 @default.
- W4323643003 cites W2631943783 @default.
- W4323643003 cites W2793659838 @default.
- W4323643003 cites W2888053719 @default.
- W4323643003 cites W2892027944 @default.
- W4323643003 cites W2955895336 @default.
- W4323643003 cites W3006116566 @default.
- W4323643003 cites W3082797589 @default.
- W4323643003 cites W3137044348 @default.
- W4323643003 cites W3183402545 @default.
- W4323643003 cites W4205186352 @default.
- W4323643003 cites W4289519172 @default.
- W4323643003 cites W4321429263 @default.
- W4323643003 cites W65377277 @default.
- W4323643003 doi "https://doi.org/10.5551/jat.64091" @default.
- W4323643003 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36889737" @default.
- W4323643003 hasPublicationYear "2023" @default.
- W4323643003 type Work @default.
- W4323643003 citedByCount "0" @default.
- W4323643003 crossrefType "journal-article" @default.
- W4323643003 hasAuthorship W4323643003A5002054394 @default.
- W4323643003 hasAuthorship W4323643003A5023712329 @default.
- W4323643003 hasAuthorship W4323643003A5029722966 @default.
- W4323643003 hasAuthorship W4323643003A5034236679 @default.
- W4323643003 hasAuthorship W4323643003A5040423588 @default.
- W4323643003 hasAuthorship W4323643003A5059106599 @default.
- W4323643003 hasAuthorship W4323643003A5067280358 @default.
- W4323643003 hasAuthorship W4323643003A5068758580 @default.
- W4323643003 hasAuthorship W4323643003A5085405229 @default.
- W4323643003 hasAuthorship W4323643003A5087008302 @default.
- W4323643003 hasAuthorship W4323643003A5088588767 @default.
- W4323643003 hasAuthorship W4323643003A5089100272 @default.
- W4323643003 hasBestOaLocation W43236430031 @default.
- W4323643003 hasConcept C126322002 @default.
- W4323643003 hasConcept C141071460 @default.
- W4323643003 hasConcept C164705383 @default.
- W4323643003 hasConcept C197934379 @default.
- W4323643003 hasConcept C2776151105 @default.
- W4323643003 hasConcept C2776204877 @default.
- W4323643003 hasConcept C2778163477 @default.
- W4323643003 hasConcept C2778401633 @default.
- W4323643003 hasConcept C2778913445 @default.
- W4323643003 hasConcept C2779620165 @default.
- W4323643003 hasConcept C2780072125 @default.
- W4323643003 hasConcept C71924100 @default.
- W4323643003 hasConcept C90924648 @default.
- W4323643003 hasConceptScore W4323643003C126322002 @default.
- W4323643003 hasConceptScore W4323643003C141071460 @default.
- W4323643003 hasConceptScore W4323643003C164705383 @default.
- W4323643003 hasConceptScore W4323643003C197934379 @default.
- W4323643003 hasConceptScore W4323643003C2776151105 @default.
- W4323643003 hasConceptScore W4323643003C2776204877 @default.
- W4323643003 hasConceptScore W4323643003C2778163477 @default.
- W4323643003 hasConceptScore W4323643003C2778401633 @default.
- W4323643003 hasConceptScore W4323643003C2778913445 @default.
- W4323643003 hasConceptScore W4323643003C2779620165 @default.
- W4323643003 hasConceptScore W4323643003C2780072125 @default.
- W4323643003 hasConceptScore W4323643003C71924100 @default.
- W4323643003 hasConceptScore W4323643003C90924648 @default.
- W4323643003 hasLocation W43236430031 @default.
- W4323643003 hasLocation W43236430032 @default.
- W4323643003 hasOpenAccess W4323643003 @default.
- W4323643003 hasPrimaryLocation W43236430031 @default.
- W4323643003 hasRelatedWork W1984812090 @default.
- W4323643003 hasRelatedWork W1996561303 @default.
- W4323643003 hasRelatedWork W2038672222 @default.
- W4323643003 hasRelatedWork W2081718785 @default.
- W4323643003 hasRelatedWork W2100236100 @default.
- W4323643003 hasRelatedWork W2103393903 @default.
- W4323643003 hasRelatedWork W2124135994 @default.
- W4323643003 hasRelatedWork W2134715975 @default.
- W4323643003 hasRelatedWork W2383516380 @default.
- W4323643003 hasRelatedWork W2606610653 @default.